Lv11
50 积分 2024-06-07 加入
Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse
3小时前
已完结
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
19天前
已完结
Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment
3个月前
已完结
Increased PD-1 expression of bone marrow T-cells in acute myeloid leukaemia patients after stem cell transplantation, and its association with overall survival
3个月前
已关闭
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
3个月前
已完结
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL
5个月前
已关闭
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
5个月前
已关闭
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
5个月前
已关闭
Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
5个月前
已关闭
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation
9个月前
已完结
皖公网安备34019202002308
